QbD assisted development of inhalable spray-dried erlotinib procubosomal system for the effective management of non-small cell lung cancer

Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int. J. Cancer, 136, E359, 10.1002/ijc.29210 Foroughi-Nia, 2021, Progresses in polymeric nanoparticles for delivery of tyrosine kinase inhibitors, Life Sci., 278, 10.1016/j.lfs.2021.119642 Singh, 2019, Inhalable nanostructures for lung cancer treatment: progress and challenges, Current Nanomedicine (Formerly: Recent Pat. Nanomed., 9, 4, 10.2174/2468187308666180307152049 Shepard, 2021, Local treatment of non-small cell lung cancer with a spray-dried bevacizumab formulation, AAPS PharmSciTech, 22, 230, 10.1208/s12249-021-02095-7 Chauhan, 2023, Scalable production and in vitro efficacy of inhaled erlotinib nanoemulsion for enhanced efficacy in non-small cell lung cancer (NSCLC), Pharmaceutics, 15, 996, 10.3390/pharmaceutics15030996 Devasari, 2015, Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: preparation, characterization, in silico, in vitro and in vivo evaluation, Carbohydr. Polym., 134, 547, 10.1016/j.carbpol.2015.08.012 Bakhtiary, 2017, Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer, Drug Dev. Ind. Pharm., 43, 1244, 10.1080/03639045.2017.1310223 Kim, 2017, PEGylated polypeptide lipid nanocapsules to enhance the anticancer efficacy of erlotinib in non-small cell lung cancer, Colloids Surf. B Biointerfaces, 150, 393, 10.1016/j.colsurfb.2016.11.002 Soni, 2020, QbD based approach for formulation development of spray dried microparticles of erlotinib hydrochloride for sustained release, J. Drug Deliv. Sci. Technol., 57 Vaidya, 2019, Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer, Int. J. Biol. Macromol., 122, 338, 10.1016/j.ijbiomac.2018.10.181 Jain, 2022, Enhanced stability and oral bioavailability of erlotinib by solid self nano emulsifying drug delivery systems, Int. J. Pharm., 622, 10.1016/j.ijpharm.2022.121852 Dora, 2016, Potential of erlotinib cyclodextrin nanosponge complex to enhance solubility, dissolution rate, in vitro cytotoxicity and oral bioavailability, Carbohydr. Polym., 137, 339, 10.1016/j.carbpol.2015.10.080 Fathi, 2017, Folate-conjugated thermosensitive O-maleoyl modified chitosan micellar nanoparticles for targeted delivery of erlotinib, Carbohydr. Polym., 172, 130, 10.1016/j.carbpol.2017.05.007 Erdoğar, 2021, Erlotinib complexation with randomly methylated β-cyclodextrin improves drug solubility, intestinal permeability, and therapeutic efficacy in non-small cell lung cancer, Pharmaceut. Dev. Technol., 26, 797, 10.1080/10837450.2021.1946695 Tan, 2017, Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo, Drug Des. Dev. Ther., 3519, 10.2147/DDDT.S151422 Varan, 2021, Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver, J. Drug Target., 29, 439, 10.1080/1061186X.2020.1853743 Szabová, 2023, Liposomal form of erlotinib for local inhalation administration and efficiency of its transport to the lungs, Int. J. Pharm., 634, 10.1016/j.ijpharm.2023.122695 Dhoble, 2021, Site-specific delivery of inhalable antiangiogenic liposomal dry powder inhaler technology ameliorates experimental pulmonary hypertension, J. Drug Deliv. Sci. Technol., 62 Mansour, 2012, Lipid nanoparticulate drug delivery and nanomedicine, 221 Chow, 2007, Particle engineering for pulmonary drug delivery, Pharmaceut. Res., 24, 411, 10.1007/s11095-006-9174-3 Shahin, 2019, Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension, J. Contr. Release, 302, 126, 10.1016/j.jconrel.2019.03.029 Vanza, 2022, Afatinib liposomal dry powder inhaler: targeted pulmonary delivery of EGFR inhibitor for the management of lung cancer, J. Drug Deliv. Sci. Technol., 74 Meenach, 2013, Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer, Eur. J. Pharmaceut. Sci., 49, 699, 10.1016/j.ejps.2013.05.012 Muheem, 2017, A combinatorial statistical design approach to optimize the nanostructured cubosomal carrier system for oral delivery of ubidecarenone for management of doxorubicin-induced cardiotoxicity: in vitro–in vivo investigations, J. Pharmaceut. Sci., 106, 3050, 10.1016/j.xphs.2017.05.026 Chang, 2021, Comparison of cubosomes and liposomes for the encapsulation and delivery of curcumin, Soft Matter, 17, 3306, 10.1039/D0SM01655A Flak, 2020, AT101-loaded cubosomes as an alternative for improved glioblastoma therapy, Int. J. Nanomed., 15, 7415, 10.2147/IJN.S265061 2009, Harmonised tripartite guideline: pharmaceutical development Q8 (R2) Khatib, 2021, Modeling of a spray drying method to produce ciprofloxacin nanocrystals inside the liposomes utilizing a response surface methodology: Box-Behnken experimental design, Int. J. Pharm., 597, 10.1016/j.ijpharm.2021.120277 Rizwan, 2011, Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines, Eur. J. Pharm. Biopharm., 79, 15, 10.1016/j.ejpb.2010.12.034 Nielsen, 2017, Microcontainers as an oral delivery system for spray dried cubosomes containing ovalbumin, Eur. J. Pharm. Biopharm., 118, 13, 10.1016/j.ejpb.2016.12.008 Moebus, 2012, Cubic phase-forming dry powders for controlled drug delivery on mucosal surfaces, J. Contr. Release, 157, 206, 10.1016/j.jconrel.2011.09.075 Spicer, 2002, Dry powder precursors of cubic liquid crystalline nanoparticles (cubosomes), J. Nanoparticle Res., 4, 297, 10.1023/A:1021184216308 Adel, 2021, Design and characterization of spray-dried proliposomes for the pulmonary delivery of curcumin, Int. J. Nanomed., 16, 2667, 10.2147/IJN.S306831 Singh, 2021, Exploration of modified cyclone separator for the enhanced recovery of inhalable spray dried cubosomal powder intended to be used for lung delivery, J. Drug Deliv. Sci. Technol., 66 Commission, 2007 Park, 2013, Chitosan microspheres as an alveolar macrophage delivery system of ofloxacin via pulmonary inhalation, Int. J. Pharm., 441, 562, 10.1016/j.ijpharm.2012.10.044 Nasr, 2016, Sorbitol based powder precursor of cubosomes as an oral delivery system for improved bioavailability of poorly water soluble drugs, J. Drug Deliv. Sci. Technol., 35, 106, 10.1016/j.jddst.2016.06.011 Dhoble, 2019, Development of anti-angiogenic erlotinib liposomal formulation for pulmonary hypertension: a QbD approach, Drug Delivery Transl. Res., 9, 980, 10.1007/s13346-019-00641-2 Pharmacopeia, 2016 Singh, 2017, QbD based synthesis and characterization of polyacrylamide grafted corn fibre gum, Carbohydr. Polym., 156, 45, 10.1016/j.carbpol.2016.08.089 Kamboj, 2014, Physicochemical, rheological and antioxidant potential of corn fiber gum, Food Hydrocolloids, 39, 1, 10.1016/j.foodhyd.2013.12.015 Colombo, 2008, Platinum, palladium and rhodium release from vehicle exhaust catalysts and road dust exposed to simulated lung fluids, Ecotoxicol. Environ. Saf., 71, 722, 10.1016/j.ecoenv.2007.11.011 Mulla, 2017, Development of respirable rifampicin-loaded nano-lipomer composites by microemulsion-spray drying for pulmonary delivery, J. Drug Deliv. Sci. Technol., 41, 13, 10.1016/j.jddst.2017.06.017 Tahir, 2017, Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications, Int. J. Pharm., 533, 156, 10.1016/j.ijpharm.2017.09.061 Guideline, 2003, Stability testing of new drug substances and products, Q1A (R2), current step, 4, 1 Ong, 2012, Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia, Pharmaceut. Res., 29, 3335, 10.1007/s11095-012-0827-0 Cingolani, 2019, In vitro investigation on the impact of airway mucus on drug dissolution and absorption at the air-epithelium interface in the lungs, Eur. J. Pharm. Biopharm., 141, 210, 10.1016/j.ejpb.2019.05.022 Ong, 2011, Epithelial profiling of antibiotic controlled release respiratory formulations, Pharmaceut. Res., 28, 2327, 10.1007/s11095-011-0462-1 Trammer, 2008, Comparative permeability and diffusion kinetics of cyclosporine A liposomes and propylene glycol solution from human lung tissue into human blood ex vivo, Eur. J. Pharm. Biopharm., 70, 758, 10.1016/j.ejpb.2008.07.001 Shah, 2018, Facile synthesis of chitosan capped mesoporous silica nanoparticles: a pH responsive smart delivery platform for raloxifene hydrochloride, AAPS PharmSciTech, 19, 1344, 10.1208/s12249-017-0949-0 Sethi, 2021, Exploring the feasibility of carbamoylethyl pullulan-g-palmitic acid polymeric micelles for the effective targeting of raloxifene to breast tumor: optimization and preclinical evaluation, Int. J. Pharm., 603, 10.1016/j.ijpharm.2021.120720 Avedian, 2018, pH-sensitive biocompatible mesoporous magnetic nanoparticles labeled with folic acid as an efficient carrier for controlled anticancer drug delivery, J. Drug Deliv. Sci. Technol., 44, 323, 10.1016/j.jddst.2018.01.006 Patel, 2019, Erlotinib-valproic acid liquisolid formulation: evaluating oral bioavailability and cytotoxicity in erlotinib-resistant non-small cell lung cancer cells, AAPS PharmSciTech, 20, 1, 10.1208/s12249-019-1332-0 Lizio, 2001, Oral endotracheal intubation of rats for intratracheal instillation and aerosol drug delivery, Lab. Anim, 35, 257, 10.1258/0023677011911723 Chaurasiya, 2018, Design and validation of a simple device for insufflation of dry powders in a mice model, Eur. J. Pharmaceut. Sci., 123, 495, 10.1016/j.ejps.2018.08.010 Zhang, 2016, Edible ginger-derived nanoparticles: a novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer, Biomaterials, 101, 321, 10.1016/j.biomaterials.2016.06.018 Shishir, 2016, Optimization of spray drying parameters for pink guava powder using RSM, Food Sci. Biotechnol., 25, 461, 10.1007/s10068-016-0064-0 Pardeshi, 2020, Preparation and characterization of sustained release pirfenidone loaded microparticles for pulmonary drug delivery: spray drying approach, Dry. Technol., 39, 337, 10.1080/07373937.2020.1833213 Sengel-Turk, 2017, Design of lipid-polymer hybrid nanoparticles for therapy of BPH: Part I. Formulation optimization using a design of experiment approach, J. Drug Deliv. Sci. Technol., 39, 16, 10.1016/j.jddst.2017.02.012 Eldeeb, 2019, Formulation and evaluation of cubosomes drug delivery system for treatment of glaucoma: ex-vivo permeation and in-vivo pharmacodynamic study, J. Drug Deliv. Sci. Technol., 52, 236, 10.1016/j.jddst.2019.04.036 Bera, 2020, Core-shell structured pullulan based nanocomposites as erlotinib delivery shuttles, Int. J. Polym. Mater. Polym. Biomater., 69, 848, 10.1080/00914037.2019.1626389 Mandal, 2016, Development and in vitro evaluation of core–shell type lipid–polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer, Eur. J. Pharmaceut. Sci., 81, 162, 10.1016/j.ejps.2015.10.021 Abdelgalil, 2020, 93, 10.1016/bs.podrm.2019.10.004 Ghan, 2022, Palm olein organogelation using mixtures of soy lecithin and glyceryl monostearate, Gels, 8, 30, 10.3390/gels8010030 Jia, 2015, Synthesis and characterization of glyceryl monooleate-based polyester, Kor. J. Chem. Eng., 32, 547, 10.1007/s11814-014-0214-0 Karolewicz, 2017, Pluronic F127 as a suitable carrier for preparing the imatinib base solid dispersions and its potential in development of a modified release dosage forms, J. Therm. Anal. Calorim., 130, 383, 10.1007/s10973-017-6139-1 Shameli, 2012, Synthesis and characterization of polyethylene glycol mediated silver nanoparticles by the green method, Int. J. Mol. Sci., 13, 6639, 10.3390/ijms13066639 Xie, 2012, Facile synthesis, spectral properties and formation mechanism of sulfur nanorods in PEG-200, Mater. Res. Bull., 47, 3665, 10.1016/j.materresbull.2012.06.043 Gupta, 2018, Paclitaxel and erlotinib-co-loaded solid lipid core nanocapsules: assessment of physicochemical characteristics and cytotoxicity in non-small cell lung cancer, Pharmaceut. Res., 35, 1, 10.1007/s11095-017-2337-6 Molina, 2019, The crucial role of leucine concentration on spray dried mannitol-leucine as a single carrier to enhance the aerosolization performance of Albuterol sulfate, J. Drug Deliv. Sci. Technol., 49, 97, 10.1016/j.jddst.2018.11.007 Hu, 2018, Preparation of drug nanocrystals embedded in mannitol microcrystals via liquid antisolvent precipitation followed by immediate (on-line) spray drying, Adv. Powder Technol., 29, 957, 10.1016/j.apt.2018.01.013 Leung, 2016, Production of inhalation phage powders using spray freeze drying and spray drying techniques for treatment of respiratory infections, Pharmaceut. Res., 33, 1486, 10.1007/s11095-016-1892-6 Reddy, 2013 Guimarães, 2015, A multivariate approach applied to quality on particle engineering of spray-dried mannitol, Adv. Powder Technol., 26, 1094, 10.1016/j.apt.2015.05.004 Li, 2014, Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers, J. Aerosol Med. Pulm. Drug Deliv., 27, 81, 10.1089/jamp.2013.1078 Patil, 2021, Inhalable bedaquiline-loaded cubosomes for the treatment of non-small cell lung cancer (NSCLC), Int. J. Pharm., 607, 10.1016/j.ijpharm.2021.121046 Kazi, 2020, Development of inhalable cubosome nanoparticles of Nystatin for effective management of Invasive Pulmonary Aspergillosis, J. Fac. Pharm. Istanb. Univ., 50, 224 Tayel, 2015, Duodenum-triggered delivery of pravastatin sodium via enteric surface-coated nanovesicular spanlastic dispersions: development, characterization and pharmacokinetic assessments, Int. J. Pharm., 483, 77, 10.1016/j.ijpharm.2015.02.012 Venkataramani, 2013, Thermal stability of high concentration lysozyme across varying pH: a Fourier Transform Infrared study, J. Pharm. BioAllied Sci., 5, 148, 10.4103/0975-7406.111821 Yaghmur, 2021, Recent advances in drug delivery applications of cubosomes, hexosomes, and solid lipid nanoparticles, Acta Pharm. Sin. B, 11, 871, 10.1016/j.apsb.2021.02.013 Tu, 2014, Preparation, characterisation and evaluation of curcumin with piperine-loaded cubosome nanoparticles, J. Microencapsul., 31, 551, 10.3109/02652048.2014.885607 Zhou, 2018, Development of a nanoliposomal formulation of erlotinib for lung cancer and in vitro/in vivo antitumoral evaluation, Drug Des. Dev. Ther., 12, 1, 10.2147/DDDT.S146925 Ong, 2014, In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation, Eur. J. Pharm. Biopharm., 86, 83, 10.1016/j.ejpb.2013.06.024 Liu, 2017, Paclitaxel and quercetin nanoparticles co-loaded in microspheres to prolong retention time for pulmonary drug delivery, Int. J. Nanomed., 8239, 10.2147/IJN.S147028